Treatment of Erectile Dysfunction with Chronic Dosing of Tadalafil

European Urology

Volumn 50, Issue 2, 2006, Pages 215-217

  McMahon, Chris G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL; TADALAFIL;

BACKACHE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC DRUG ADMINISTRATION; CLINICAL FEATURE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; DYSPEPSIA; EDITORIAL; ENDOTHELIAL DYSFUNCTION; ERECTILE DYSFUNCTION; HUMAN; HYPERTENSION; LONG TERM CARE; MYALGIA; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PENIS ERECTION; PRESCRIPTION; PRIORITY JOURNAL; SEXUAL INTERCOURSE; TREATMENT OUTCOME;

CARBOLINES; ERECTILE DYSFUNCTION; HUMANS; MALE; PHOSPHODIESTERASE INHIBITORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 33745821227     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2006.03.018     Document Type: Editorial

References (16)

1. Azadzoi K.M., and Saenz de Tejada I. Hypercholesterolemia impairs endothelium-dependent relaxation of rabbit corpus cavernosum smooth muscle. J Urol 146 (1991) 238-240
2. Saenz de Tejada I., Goldstein I., Azadzoi K., Krane R.J., and Cohen R.A. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med 320 (1989) 1025-1030
3. Kaiser D.R., Billups K., Mason C., Wetterling R., Lundberg J.L., and Bank A.J. Impaired brachial artery endothelium-dependent and -independent vasodilation in men with erectile dysfunction and no other clinical cardiovascular disease. J Am Coll Cardiol 43 (2004) 179-184
4. Desouza C., Parulkar A., Lumpkin D., Akers D., and Fonseca V.A. Acute and prolonged effects of sildenafil on brachial artery flow-mediated dilatation in type 2 diabetes. Diabetes Care 25 (2002) 1336-1339
5. Kimura M., Higashi Y., Hara K., et al. PDE5 inhibitor sildenafil citrate augments endothelium-dependent vasodilation in smokers. Hypertension 41 (2003) 1106-1110 Epub 2003 Apr 14
6. Katz S.D., Balidemaj K., Homma S., Wu H., Wang J., and Maybaum S. Acute type 5 phosphodiesterase inhibition with sildenafil enhances flow-mediated vasodilation in patients with chronic heart failure. J Am Coll Cardiol 36 (2000) 845-851
7. Rosano G.M.C., Aversa A., Vitale C., Fabbri A., Fini M., and Spera G. Chronic treatment with tadalafil improves endothelial function in men with increased cardiovascular risk. Eur Urol 47 (2005) 214-220
8. Caretta N., Palego P., Ferlin A., et al. Resumption of spontaneous erections in selected patients affected by erectile dysfunction and various degrees of carotid wall alteration: role of tadalafil. Eur Urol 48 (2005) 326-331
9. Behr-Roussel D., Gorny D., Mevel K., et al. Chronic sildenafil enhances erectile responses and endothelium-dependent corporal relaxations of normal rats: lack of tachyphylaxis. J Urol 171 (2004) 425
10. Jackson G. Hemodynamic and exercise effects of phosphodiesterase 5 inhibitors. Am J Cardiol 96 (2005) 32M-36M
11. Porst H., Giuliano F., Glina S., et al. Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5 mg and 10 mg in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial. Eur Urol. 50 (2006) 351-359
12. McMahon C.G. Efficacy and safety of daily tadalafil in men with erectile dysfunction previously unresponsive to on-demand tadalafil. J Sex Med 1 (2004) 292-300
13. McMahon C.G. Comparison of efficacy, safety, and tolerability of on-demand tadalafil and daily dosed tadalafil for the treatment of erectile dysfunction. J Sex Med 2 (2005) 415-425
14. Mirone V., Costa P., Damber J.E., et al. An evaluation of an alternative dosing regimen with tadalafil, 3 times/week, for men with erectile dysfunction: SURE study in 14 European countries. Eur Urol 47 (2005) 846-854
15. Levine L.A., McCullough A.R., and Padma-Nathan H. Longitudinal randomized placebo-controlled study of the return of nocturnal erections after nerve-sparing radical prostatectomy in men treated with nightly sildenafil citrate. J Urol 171 (2004) 231
16. Eardley I., Mirone V., Montorsi F., et al. An open-label, multicentre, randomized, crossover study comparing sildenafil citrate and tadalafil for treating erectile dysfunction in men naive to phosphodiesterase 5 inhibitor therapy. BJU Int 96 (2005) 1323-1332